Clinical trial
Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic…
NCT00423826 · Barbara Ann Karmanos Cancer Institute, Other · No longer available
Key facts
| NCT number | NCT00423826 |
|---|---|
| Title | Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease |
| Official title | A Pilot Study of Double Cord Blood Stem Cell Transplantation in Patients With Hematologic Malignancies |
| Lead sponsor | Barbara Ann Karmanos Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | No longer available |
| Study type | Expanded Access |
| Conditions | Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Precancerous Condition, Secondary Myelofibrosis |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | Busulfan, Cytarabine, Fludarabine phosphate, mycophenolate mofetil, tacrolimus, allogeneic hematopoietic stem cell transplantation, umbilical cord blood transplantation, total-body irradiation |
| Start date | Jan 1, 2007 |
| Primary completion | Jan 1, 2015 |
| Completion | Jan 1, 2015 |
| First posted | Jan 18, 2007 |
| Last update posted | Feb 29, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: